• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

原癌基因核受体4A(NR4A)调控基因β1整合素和G9a的表达受双NR4A1/2配体抑制。

Expression of Prooncogenic Nuclear Receptor 4A (NR4A)-Regulated Genes β1-Integrin and G9a Inhibited by Dual NR4A1/2 Ligands.

作者信息

Zhang Lei, Gatlin Victoria, Gupta Shreyan, Salinas Michael L, Romero Selim, Cai James J, Chapkin Robert S, Safe Stephen

机构信息

Department of Veterinary Physiology and Pharmacology, Texas A&M University, College Station, TX 77843, USA.

Department of Veterinary Integrative Biosciences, School of Veterinary Medicine and Biomedical Sciences, Texas A&M University, College Station, TX 77843, USA.

出版信息

Int J Mol Sci. 2025 Apr 21;26(8):3909. doi: 10.3390/ijms26083909.

DOI:10.3390/ijms26083909
PMID:40332813
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12028307/
Abstract

Bis-indole-derived compounds including 1,1-bis(3'-indolyl)-1-(3,5-disubstitutedphenyl)methane (DIM-3,5) analogs bind both orphan nuclear receptors 4A1 (NR4A1) and NR4A2, and DIM-3,5 compounds act as dual receptor inverse agonists and inhibit both NR4A1- and NR4A2-regulated responses. Chromatin immunoprecipitation assays show that β1-integrin and the methyltransferase gene G9a are regulated by both NR4A1 and NR4A2 acting as cofactors for Sp1- and Sp4-dependent gene expression. DIM-3,5 treatment results in the loss of one or more of these nuclear factors from the β1-integrin and G9a promoters. Single-cell and RNAseq analyses show that both receptors regulate common (<10%) and unique genes in SW480 colon cancer cells; however, functional enrichment analysis of the differentially expressed genes converges to several common pathways and gene ontology terms.

摘要

双吲哚衍生化合物,包括1,1 - 双(3'-吲哚基)-1-(3,5 - 二取代苯基)甲烷(DIM - 3,5)类似物,可与孤儿核受体4A1(NR4A1)和NR4A2结合,并且DIM - 3,5化合物作为双受体反向激动剂,抑制NR4A1和NR4A2调节的反应。染色质免疫沉淀分析表明,β1整合素和甲基转移酶基因G9a受NR4A1和NR4A2调控,它们作为Sp1和Sp4依赖性基因表达的辅助因子。DIM - 3,5处理导致这些核因子中的一种或多种从β1整合素和G9a启动子上缺失。单细胞和RNA测序分析表明,这两种受体在SW480结肠癌细胞中调节共同的(<10%)和独特的基因;然而,差异表达基因的功能富集分析汇聚到几个共同的途径和基因本体术语。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/134a/12028307/9e9ee76182f0/ijms-26-03909-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/134a/12028307/3cb99c0674d2/ijms-26-03909-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/134a/12028307/4568fff51f0c/ijms-26-03909-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/134a/12028307/15472d18ac62/ijms-26-03909-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/134a/12028307/7624771b52a1/ijms-26-03909-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/134a/12028307/3555904ba4d4/ijms-26-03909-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/134a/12028307/64a2e522fe89/ijms-26-03909-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/134a/12028307/9e9ee76182f0/ijms-26-03909-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/134a/12028307/3cb99c0674d2/ijms-26-03909-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/134a/12028307/4568fff51f0c/ijms-26-03909-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/134a/12028307/15472d18ac62/ijms-26-03909-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/134a/12028307/7624771b52a1/ijms-26-03909-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/134a/12028307/3555904ba4d4/ijms-26-03909-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/134a/12028307/64a2e522fe89/ijms-26-03909-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/134a/12028307/9e9ee76182f0/ijms-26-03909-g007.jpg

相似文献

1
Expression of Prooncogenic Nuclear Receptor 4A (NR4A)-Regulated Genes β1-Integrin and G9a Inhibited by Dual NR4A1/2 Ligands.原癌基因核受体4A(NR4A)调控基因β1整合素和G9a的表达受双NR4A1/2配体抑制。
Int J Mol Sci. 2025 Apr 21;26(8):3909. doi: 10.3390/ijms26083909.
2
Dual nuclear receptor 4A1 (NR4A1/NR4A2) ligands inhibit glioblastoma growth and target TWIST1.双核受体4A1(NR4A1/NR4A2)配体抑制胶质母细胞瘤生长并以TWIST1为靶点。
Mol Pharmacol. 2025 Feb;107(2):100009. doi: 10.1016/j.molpha.2024.100009. Epub 2024 Dec 31.
3
Orphan Nuclear Receptor 4A1 (NR4A1) and NR4A2are Endogenous Regulators of CD71 and TheirLigands Induce Ferroptosis in Breast Cancer.孤儿核受体4A1(NR4A1)和NR4A2是CD71的内源性调节因子,其配体可诱导乳腺癌发生铁死亡。
Res Sq. 2025 Apr 21:rs.3.rs-6214709. doi: 10.21203/rs.3.rs-6214709/v1.
4
Bis-Indole Derivatives as Dual Nuclear Receptor 4A1 (NR4A1) and NR4A2 Ligands.双吲哚衍生物作为双重核受体 4A1(NR4A1)和 NR4A2 配体。
Biomolecules. 2024 Feb 27;14(3):284. doi: 10.3390/biom14030284.
5
The nuclear orphan receptor NR4A1 regulates β1-integrin expression in pancreatic and colon cancer cells and can be targeted by NR4A1 antagonists.核孤儿受体NR4A1调节胰腺癌细胞和结肠癌细胞中的β1整合素表达,并且可被NR4A1拮抗剂靶向作用。
Mol Carcinog. 2017 Sep;56(9):2066-2075. doi: 10.1002/mc.22662. Epub 2017 May 9.
6
Natural products and synthetic analogs as selective orphan nuclear receptor 4A (NR4A) modulators.作为选择性孤儿核受体4A(NR4A)调节剂的天然产物及合成类似物。
Histol Histopathol. 2024 May;39(5):543-556. doi: 10.14670/HH-18-689. Epub 2023 Dec 13.
7
The Histone Methyltransferase Gene G9A Is Regulated by Nuclear Receptor 4A1 in Alveolar Rhabdomyosarcoma Cells.组蛋白甲基转移酶基因 G9A 在肺泡横纹肌肉瘤细胞中受核受体 4A1 调控。
Mol Cancer Ther. 2021 Mar;20(3):612-622. doi: 10.1158/1535-7163.MCT-20-0474. Epub 2020 Dec 4.
8
Potent inhibition of breast cancer by bis-indole-derived nuclear receptor 4A1 (NR4A1) antagonists.双吲哚衍生核受体 4A1(NR4A1)拮抗剂强烈抑制乳腺癌。
Breast Cancer Res Treat. 2019 Aug;177(1):29-40. doi: 10.1007/s10549-019-05279-9. Epub 2019 May 22.
9
Targeting the nuclear orphan receptor NR4A1: a key target in lung cancer progression and therapeutic resistance.靶向核孤儿受体NR4A1:肺癌进展和治疗耐药性的关键靶点。
Front Oncol. 2025 Jul 1;15:1566598. doi: 10.3389/fonc.2025.1566598. eCollection 2025.
10
Nuclear receptor 4A1 (NR4A1) as a drug target for treating rhabdomyosarcoma (RMS).核受体4A1(NR4A1)作为治疗横纹肌肉瘤(RMS)的药物靶点。
Oncotarget. 2016 May 24;7(21):31257-69. doi: 10.18632/oncotarget.9112.

本文引用的文献

1
Dual nuclear receptor 4A1 (NR4A1/NR4A2) ligands inhibit glioblastoma growth and target TWIST1.双核受体4A1(NR4A1/NR4A2)配体抑制胶质母细胞瘤生长并以TWIST1为靶点。
Mol Pharmacol. 2025 Feb;107(2):100009. doi: 10.1016/j.molpha.2024.100009. Epub 2024 Dec 31.
2
Activation of Genes by Nuclear Receptor/Specificity Protein (Sp) Interactions in Cancer.核受体/特异性蛋白(Sp)相互作用在癌症中对基因的激活作用
Cancers (Basel). 2025 Jan 17;17(2):284. doi: 10.3390/cancers17020284.
3
Combined Effects of Physical Activity and Diet on Cancer Patients: A Systematic Review and Meta-Analysis.
体力活动与饮食相结合对癌症患者的影响:系统评价和荟萃分析。
Nutrients. 2024 Jun 2;16(11):1749. doi: 10.3390/nu16111749.
4
Bis-Indole Derivatives as Dual Nuclear Receptor 4A1 (NR4A1) and NR4A2 Ligands.双吲哚衍生物作为双重核受体 4A1(NR4A1)和 NR4A2 配体。
Biomolecules. 2024 Feb 27;14(3):284. doi: 10.3390/biom14030284.
5
Bis-indole-derived NR4A1 antagonists inhibit colon tumor and splenic growth and T-cell exhaustion.双吲哚衍生的 NR4A1 拮抗剂抑制结肠肿瘤和脾脏生长以及 T 细胞耗竭。
Cancer Immunol Immunother. 2023 Dec;72(12):3985-3999. doi: 10.1007/s00262-023-03530-3. Epub 2023 Oct 17.
6
ROS-Sp1 axis is involved in thermochemotherapy-enhanced sensitivity of pancreatic cancer cells to gemcitabine.ROS-Sp1轴参与热化疗增强胰腺癌细胞对吉西他滨的敏感性。
Cell Biol Int. 2023 Nov;47(11):1825-1834. doi: 10.1002/cbin.12073. Epub 2023 Aug 6.
7
Nuclear receptor Nur77: its role in chronic inflammatory diseases.核受体 Nur77:在慢性炎症性疾病中的作用。
Essays Biochem. 2021 Dec 17;65(6):927-939. doi: 10.1042/EBC20210004.
8
NR4A1 Ligands as Potent Inhibitors of Breast Cancer Cell and Tumor Growth.NR4A1配体作为乳腺癌细胞和肿瘤生长的强效抑制剂
Cancers (Basel). 2021 May 29;13(11):2682. doi: 10.3390/cancers13112682.
9
The Paradoxical Roles of Orphan Nuclear Receptor 4A (NR4A) in Cancer.孤儿核受体 4A(NR4A)在癌症中的矛盾作用。
Mol Cancer Res. 2021 Feb;19(2):180-191. doi: 10.1158/1541-7786.MCR-20-0707. Epub 2020 Oct 26.
10
Early stage colon cancer: Current treatment standards, evolving paradigms, and future directions.早期结肠癌:当前治疗标准、不断演变的模式及未来方向。
World J Gastrointest Oncol. 2020 Aug 15;12(8):808-832. doi: 10.4251/wjgo.v12.i8.808.